Mansoura conventional electrophysiological study and ablation registry at time between march 2020 to march 2021

Fathalla Ahmed Elmanakhley; Mahmoud Mohammed Youssef; Ibrahim Elsayed Youssry

doi:10.53730/ijhs.v5nS1.14289

Authors

Fathalla Ahmed Elmanakhley Department of Cardiology, Faculty of Medicine, Mansoura University, Egypt
Mahmoud Mohammed Youssef Department of Cardiology, Faculty of Medicine, Mansoura University, Egypt
Ibrahim Elsayed Youssry
ibrahimyoussri@gmail.com
Department of Cardiology, Faculty of Medicine, Mansoura University, Egypt

Keywords:

catheter ablation, cardiac arrhythmias, Egypt

Abstract

Background: Catheter ablation has been described as a standard therapy for cardiac tachyarrhythmias. Although multiple registries have been reported from different geographical regions, like Europe and the USA, little is known about the criteria and outcomes of such patients in the Egyptian setting. Herein, we report the distribution of cardiac arrhythmias, success rate, and complications of catheter ablation in our tertiary care cardiac setting. Methods: This prospective cross-sectional study included 50 patients who underwent catheter ablation for cardiac tachyarrhythmias. Results: Most patients were older than 40 years (62%). Our study revealed the following types of arrhythmias; atrioventricular reciprocating tachycardia (AVRT) (30%), atrioventricular nodal reentry tachycardia (AVNRT) (48%), atrial tachycardia (4%), Wolff-Parkinson-White syndrome (12%), and atrial flutter (6%). Decremental retrograde conduction was noted in 62% of patients, while non-decremental conduction was present in 38% of them. A slow pathway was ablated in most patients (48%), while other ablated areas included the upper and lower crista terminalis (4%), posterior septum (10%), lateral annulus either right or left one (26%), anterior septum (2%), mid septum (4%), and cavotricuspid isthmus (6%). Our general success rate was 98%. AVNRT was significantly associated with older age, as 67.7% of their patients were older than 40 years.

Downloads

Download data is not yet available.

References

Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91-e220.https://doi.org/10.1016/j.jacc.2017.10.054.

Anand RG, Rosenthal GL, Van Hare GF, Snyder CS. Is the mechanism of supraventricular tachycardia in pediatrics influenced by age, gender or ethnicity? Congenit Heart Dis. 2009;4(6):464-8.https://doi.org/10.1111/j.1747-0803.2009.00336.x.

Andrikopoulos G, Tzeis S, Vardas PE. Invasive therapy for atrial fibrillation: recent developments in ablation, navigation and mapping technology. Heart. 2011;97(3):237-43.https://doi.org/10.1136/hrt.2009.190017.

Brachmann J, Lewalter T, Kuck KH, Andresen D, Willems S, Spitzer SG, et al. Long-term symptom improvement and patient satisfaction following catheter ablation of supraventricular tachycardia: insights from the German ablation registry. Eur Heart J. 2017;38(17):1317-26.https://doi.org/10.1093/eurheartj/ehx101.

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14(10):e275-e444.https://doi.org/10.1016/j.hrthm.2017.05.012.

Díaz-Infante E, Macías Gallego A, Ferrero de Loma-Osorio Á. Spanish Catheter Ablation Registry. 11th official report of the Spanish Society of Cardiology Working Group on electrophysiology and arrhythmias (2011). Rev Esp Cardiol (Engl Ed). 2012;65(10):928-36.https://doi.org/10.1016/j.recesp.2012.06.008.

Fenelon G, Scanavacca M, Atié J, Zimerman L, Magalhães LP, Lorga Filho A, et al. Atrial fibrillation ablation in Brazil: results of the registry of the Brazilian Society of Cardiac Arrhythmias. Arq Bras Cardiol. 2007;89(5):258-62, 85-9.https://doi.org/10.1590/s0066-782x2007001700002.

Gallagher JJ, Svenson RH, Kasell JH, German LD, Bardy GH, Broughton A, et al. Catheter technique for closed-chest ablation of the atrioventricular conduction system. N Engl J Med. 1982;306(4):194-200.https://doi.org/10.1056/nejm198201283060402.

Ibáñez Criado JL, Quesada A, Cózar R. Spanish Catheter Ablation Registry. 18th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2018). Rev Esp Cardiol (Engl Ed). 2019;72(12):1031-42.https://doi.org/10.1016/j.rec.2019.08.005.

Keegan R, Aguinaga L, Fenelon G, Uribe W, Rodriguez Diez G, Scanavacca M, et al. The first Latin American Catheter Ablation Registry. Europace. 2015;17(5):794-800.https://doi.org/10.1093/europace/euu322.

Kusano K, Yamane T, Inoue K, Takegami M, Nakao YM, Miyamoto Y, et al. The Japanese Catheter Ablation Registry (J-AB): A prospective nationwide multicenter registry in Japan. Annual report in 2018. J Arrhythm. 2020;36(6):953-61.https://doi.org/10.1002/joa3.12445.

Lewalter T, Lickfett L, Weiss C, Mewis C, Spencker S, Jung W, et al. "Largest amplitude ablation" is the optimal approach for typical atrial flutter ablation: a subanalysis from the AURUM 8 study. J Cardiovasc Electrophysiol. 2012;23(5):479-85.https://doi.org/10.1111/j.1540-8167.2011.02252.x.

Mankad P, Kalahasty G. Antiarrhythmic Drugs: Risks and Benefits. Med Clin North Am. 2019;103(5):821-34.https://doi.org/10.1016/j.mcna.2019.05.004.

Moser JM, Willems S, Andresen D, Brachmann J, Eckardt L, Hoffmann E, et al. Complication Rates of Catheter Ablation of Atrial Fibrillation in Patients Aged ≥75 Years versus <75 Years-Results from the German Ablation Registry. J Cardiovasc Electrophysiol. 2017;28(3):258-65.https://doi.org/10.1111/jce.13142.

Peters NS. Catheter ablation for cardiac arrhythmias. Bmj. 2000;321(7263):716-7.https://doi.org/10.1136/bmj.321.7263.716.

Porter MJ, Morton JB, Denman R, Lin AC, Tierney S, Santucci PA, et al. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm. 2004;1(4):393-6.https://doi.org/10.1016/j.hrthm.2004.05.007.

Quesada A, Cózar R, Anguera I. Spanish Catheter Ablation Registry. 19th Official Report of the Heart Rhythm Association of the Spanish Society of Cardiology (2019). Rev Esp Cardiol (Engl Ed). 2020;73(12):1049-60.https://doi.org/10.1016/j.rec.2020.08.022.

Scheinman MM, Huang S. The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol. 2000;23(6):1020-8.https://doi.org/10.1111/j.1540-8159.2000.tb00891.x.

Scheinman MM, Morady F, Hess DS, Gonzalez R. Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. Jama. 1982;248(7):851-5

Shah D. A critical appraisal of cardiac ablation technology for catheter-based treatment of atrial fibrillation. Expert Rev Med Devices. 2011;8(1):49-55.https://doi.org/10.1586/erd.10.59.

Tisdale JE, Chung MK, Campbell KB, Hammadah M, Joglar JA, Leclerc J, et al. Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association. Circulation. 2020;142(15):e214-e33.https://doi.org/10.1161/cir.0000000000000905.

Tripathi B, Arora S, Kumar V, Abdelrahman M, Lahewala S, Dave M, et al. Temporal trends of in-hospital complications associated with catheter ablation of atrial fibrillation in the United States: An update from Nationwide Inpatient Sample database (2011-2014). J Cardiovasc Electrophysiol. 2018;29(5):715-24.https://doi.org/10.1111/jce.13471.

Yamane T, Inoue K, Kusano K, Takegami M, Nakao YM, Miyamoto Y, et al. Study design of nationwide Japanese Catheter Ablation Registry: Protocol for a prospective, multicenter, open registry. J Arrhythm. 2019;35(2):167-70.https://doi.org/10.1002/joa3.12163.